MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study

Turinetto, M.;Ricotti, A.;Marchetti, C.;Pisano, C.;Zamagni, C.;Cassani, C.;Malaguti, P.;Baldoni, A.;Scollo, P.;Scandurra, G.;Parisi, A.;Artioli, G.;Palaia, I.;Vertechy, L.;Bergamini, A.;Picardo, E.;Tuninetti, V.;Scotto, G.;Scambia, G.;Pignata, S.;Valabrega, G.

2024-01-01